REGENXBIO Inc.
Biotechnology company · Rockville, Maryland, United States · Nasdaq: RGNX
REGENXBIO Inc. is a biotechnology company headquartered in Rockville, Maryland, United States. Its shares trade on Nasdaq under the ticker RGNX. The US FDA lists 1 drug manufacturing or testing site registered to the company. It has received 4 US government small-business research awards (SBIR/STTR) from health agencies, $1 million in total, most recently in 2013. It has reported private securities offerings to the US SEC, most recently $71 million sold in a notice filed in 2015.
REGENXBIO at a glance
What does REGENXBIO do?
Operations at its FDA-registered drug sites
US government research funding
4 SBIR/STTR small-business research awards from US health agencies, $1 million in total (2010 to 2013).
Private fundraising reported to the SEC
3 Form D notices; the most recent reported $70.5 million sold (2015).
Where is REGENXBIO located?
Headquarters: Rockville, Maryland, United States
- Rockville, MarylandREGENXBIO Inc. · FDA drug site
Frequently asked questions about REGENXBIO
Where is REGENXBIO headquartered?
REGENXBIO Inc. is headquartered in Rockville, Maryland, United States.
What does REGENXBIO do?
REGENXBIO Inc. is a biotechnology company. Its FDA-registered drug sites are registered for analysis, API manufacturing and manufacturing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
Is REGENXBIO a public company?
Yes. REGENXBIO Inc. trades on Nasdaq under the ticker RGNX.
Similar companies
- Immunomic Therapeutics, Inc.Rockville, Maryland, United States
- OncoC4, Inc.Rockville, Maryland, United States
- Integrated Biotherapeutics LLCRockville, Maryland, United States
- Sanaria Inc.Rockville, Maryland, United States
- CASI Pharmaceuticals, Inc (DE)Rockville, Maryland, United States
- OncoImmune, Inc.Rockville, Maryland, United States
- Rise Therapeutics, LLCRockville, Maryland, United States
- KinaRx, Inc.Rockville, Maryland, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-24. Data licences